Clinical Trial Details

Overview

Research Study Summary

A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis

Purpose

The objective of this study is to evaluate the safety and efficacy of up to 26 weeks of treatment with calcitriol 3 mcg/g ointment when used twice daily, without occlusion, to treat pediatric subjects (2 to 17 years of age) with mild to moderate plaque psoriasis.

To Learn more

CW ID: 203132
Date Last Changed: March 8, 2016

Clinical Trial Snapshot

Phase
4
Gender
Both Male and Female
Age
2 to 17 Years
Overall Status
Recruiting
Lead Sponsor
Galderma R&D
Facility Type
N/A

Contact

USF Health Dermatology Research
University of South Florida - Morsani Center for Advanced Healthcare
13330 USF Laurel Drive
Tampa, FL 33612
Phone: (813)974-2923

View Map

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.